Classical oxazaphosphorines – metabolism and therapeutic properties – new implications
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0
Abstract
Cyclophosphamide (CPA) and ifosfamide (IFO) belong to oxazaphosphorine drugs and for a few decades have been widely used for treatment of solid tumours and haematological malignancies. Both drugs are administered in pharmacologically inactive form and require metabolic activation by cytochrome P-450 (CYP). Metabolic transformations taking place under the action of specific CYP isoenzymes lead to the formation of therapeutically essential metabolites and some toxic compounds affecting quality of therapy. The first stage of these conversions is connected with hydroxylation reactions occurring on the C-4 carbon atom within a ring and C-1 atoms of 2-chloroethyl chains. As a result of C-4 hydroxylation 4-hydroxy derivatives (4-OH-CPA and 4-OH-IFO) are formed and remain in tautomeric equilibrium with aldo compounds which in cancer cells spontaneously release cytotoxic phosphoramide mustards and urotoxic acrolein. At the same time hydroxychloroethyl compounds formed during hydroxylation of side-chains are unstable and collapse with the release of inter alia nephro- and neurotoxic chloroacetaldehyde (CAA). Due to formation of toxic metabolites it is essential to use some preventive agents such as mesna and recently examined agmatine. Since CPA and IFO are widely used anticancer drugs, their efficacy is limited not only by their toxicity but also due to occurring resistance. This resistance seems to be a result of changes of expression and activity of enzymes such as CYP and aldehyde dehydrogenase (ALDH) and increase of intracellular levels of glutathione (GSH) and glutathione S-transferase (GST). At present a few methods of overcoming this resistance are being examined including the use of metabolism modulators, antisense oligonucleotides selectively inhibiting gene expression, and introducing genes of some CYP isoenzymes to a cancer tissue.
Authors and Affiliations
Anna Sloderbach, Agnieszka Górska, Marta Sikorska, Konrad Misiura, Bogusław Hładoń
Keywords
Related Articles
- EP ID EP67221
- DOI -
- Views 141
- Downloads 0
Udział synaps elektrycznych w powstawaniu hipokampalnego rytmu theta
Obecny w zapisie hipokampalnej aktywności elektroencefalograficznej rytm theta jest przekładem modelowej oscylacji i synchronizacji zachodzącej w sieciach neuronalnych ośrodkowego układu nerwowego. Obecnie wiadomo, że u...
Rola transportera glukozy 1 (GLUT1) w diagnostyce i terapii nowotworów
Podstawową cechą komórek nowotworowych jest przyspieszony metabolizm glukozy połączony z zahamowaniem procesu fosforylacji oksydacyjnej. Zwiększone tempo glikolizy umożliwia kompensację niewielkiego zysku energetyczne...
Osmoregulation – an important parameter of bacterial growth
Environmental conditions such as temperature, pH, radiation and osmotic pressure are important factors limiting the growth and multiplication of bacteria. Regular structure and metabolism of bacterial cells are maintaine...
The use of oligonucleotide aptamers in cancer therapy
Aptamers are a new class of molecules which originated in the 1990s. They are usually RNA or DNA oligonucleotides, the length of which ranges between 20 and 80 nt. They are produced using the SELEX method that allows one...
Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia
Background: Vitamin D (VD) deficiency in chronic lymphocytic leukemia (CLL) is associated with inferior prognosis, shorter time to treatment and worse overall survival. VD deficiency is the first potentially modifiable p...